TABLE 2.
Combination index and dose reduction values for entry inhibition of Zaire-PsV infection by combining tolcapone with entry-inhibitory antivirals in semen.
Drug combination, %Inhibitory Conc. (Molar ratio) | CIa |
Tolcapone |
Entry-inhibitory antivirals |
||||
IC50(nM)b | Dose reduction | IC50(nM)b | Dose reduction | ||||
Alone Mixture | (Fold) | Alone Mixture | (Fold) | ||||
Tolcapone:Bepridil (133:1) | |||||||
50 | 0.372 | 2637.62 | 915.67 | 2.88 | 279.74 | 6.87 | 40.72 |
90 | 0.216 | 29044.10 | 5619.65 | 5.17 | 1844.83 | 42.15 | 43.77 |
Tolcapone:Sertraline (100:1) | |||||||
50 | 0.151 | 2637.62 | 356.26 | 7.40 | 219.63 | 3.56 | 61.69 |
90 | 0.534 | 29044.10 | 13009.00 | 2.23 | 1514.23 | 130.09 | 11.64 |
aCI, combination index. bData are the means of two independent experiments performed in triplicate.